Patients with head and neck cancer who attended a survivorship clinic before completing RT were more likely to complete treatment on schedule and had better 3-year DFS than those who did not attend.

As I’ve noted, the topic of GLP-1 use and its very favorable impact on health is well established, including in the suggestion that risk for cancer will be decreased. This particular analysis, which ...

In the head-to-head TRANSCEND-T2D-2 trial, participants with type 2 diabetes (T2D) lost more than twice as much weight with retatrutide as with Ozempic (semaglutide) and had a greater reduction in A1c ...

In a phase 2b trial, naronapride, an investigational dual-action prokinetic, administered at 20 or 40 mg three times daily for 12 weeks led to significantly greater improvement in core symptoms than ...

Cancer survivors who adhered to the Dietary Approaches to Stop Hypertension (DASH) diet and other healthy eating patterns showed as much as a one-third lower risk of developing cardiovascular disease ...

Nearly 3 in 4 former National Football League (NFL) players who died between 2008 and 2023 likely had chronic traumatic encephalopathy (CTE), a new study suggested. The population-based ...

A patient started on a once-daily inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) inhaler for COPD and a patient started on that same class of inhaler ...

In COPD, two single-inhaler triple therapies have trial-based mortality findings that neither current US label includes as an efficacy claim. Trelegy Ellipta ...

A patient newly diagnosed with low-symptom COPD and a patient with severe, poorly controlled asthma despite inhaled corticosteroids and a long-acting beta-agonist (LABA) may both end up on a ...

Short-acting bronchodilators remain the rescue inhalers for asthma and chronic obstructive pulmonary disease (COPD), yet the Global Initiative for Asthma (GINA) 2026 report states that asthma should ...

Patients with rheumatoid arthritis (RA) incidence in 2010-2019 achieved remission within the first year at higher rates than those diagnosed in 1990-1999. Median time to remission shortened from 6.4 ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.